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Relaxin and Estrogen Accelerate Growth of Uterine Cervix of Prepubertal
Pigs
Abstract
One of the primary targets for the biological actions of relaxin is the uterine cervix. The effects of relaxin on
this organ include inducing growth and remodeling of connective tissue and cervical cells to accommodate
pregnancy and parturition. The related physiological and clinical observations include softening, ripening, and
dilating the cervix and facilitating delivery of the young. The underlying molecular and cellular mechanisms
remain obscure. Collagen is the most abundant protein in the cervix and plays a key role in connective tissue
remodeling. This study was designed to determine the developmental and growthpromoting effects of relaxin
with or without estrogen on the uterine cervix of prepubertal gilts. Littermate gilts of 80 days old were
randomly assigned to four treatments: vehicle (control, 1 milliliter [ml.] phosphate buffer saline [PBS] and 1
ml. vegetable oil, n = 5); relaxin (relaxin, in PBS, 1 ml., 167 mg. ml. -1 , n = 5); estradiol benzoate (EB, in
vegetable oil, 1 ml., 2 mg. ml. -1 , n = 5); and relaxin plus EB (relaxin + EB, at the same doses, n = 5), total six
intramuscular injections for all treatments. Twenty-four hours after the last injection, the uterus was surgically
removed, and the uterine tissues were immediately frozen at -80°C. Homogenates of uterine horns and
cervices were analyzed for concentrations and contents of protein or hydroxyproline (collagen index) and
DNA. Relaxin alone had no significant effect on wet or dry weight of the uterus. EB alone increased
significantly (P<.05) wet weight of the uterus. In the presence of EB, relaxin treatment increased all
measurements compared with control (i.e., wet weight). Compared with EB, Relaxin + EB significantly
(P<.05) increased the uterine wet weight, the hydroxyproline content and DNA content. These results
indicate that the growth-promoting effects of relaxin on the uterus and cervix may be, at least partly, estrogen-
dependent and that the growth and development of the uterus and cervix can be accelerated by a combination
of relaxin and estrogen treatment. The present results show that the growth and development of the porcine
uterus and cervix can be accelerated by treatment with relaxin and estrogen. Although it is not known whether
the pig at this prepubertal stage contains relaxin receptors after relaxin and estrogen stimulation, the results
reported here indicate that relaxin regulates the growth and development of the uterus and cervix during
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Summary and Implications
One of the primary targets for the biological actions of
relaxin is the uterine cervix. The effects of relaxin on this
organ include inducing growth and remodeling of connective
tissue and cervical cells to accommodate pregnancy and
parturition. The related physiological and clinical
observations include softening, ripening, and dilating the
cervix and facilitating delivery of the young. The underlying
molecular and cellular mechanisms remain obscure.
Collagen is the most abundant protein in the cervix and
plays a key role in connective tissue remodeling. This study
was designed to determine the developmental and growth-
promoting effects of relaxin with or without estrogen on the
uterine cervix of prepubertal gilts.
Littermate gilts of 80 days old were randomly assigned
to four treatments: vehicle (control, 1 milliliter [ml.]
phosphate buffer saline [PBS] and 1 ml. vegetable oil, n =
5); relaxin (relaxin, in PBS, 1 ml., 167 mg. ml.-1, n = 5);
estradiol benzoate (EB, in vegetable oil, 1 ml., 2 mg. ml.-1,
n = 5); and relaxin plus EB (relaxin + EB, at the same
doses, n = 5), total six intramuscular injections for all
treatments. Twenty-four hours after the last injection, the
uterus was surgically removed, and the uterine tissues were
immediately frozen at -80°C. Homogenates of uterine horns
and cervices were analyzed for concentrations and contents of
protein or hydroxyproline (collagen index) and DNA.
Relaxin alone had no significant effect on wet or dry weight
of the uterus. EB alone increased significantly (P<.05) wet
weight of the uterus. In the presence of EB, relaxin treatment
increased all measurements compared with control (i.e., wet
weight). Compared with EB, Relaxin + EB significantly
(P<.05) increased the uterine wet weight, the
hydroxyproline content and DNA content. These results
indicate that the growth-promoting effects of relaxin on the
uterus and cervix may be, at least partly, estrogen-dependent
and that the growth and development of the uterus and
cervix can be accelerated by a combination of relaxin and
estrogen treatment.
The present results show that the growth and
development of the porcine uterus and cervix can be
accelerated by treatment with relaxin and estrogen.
Although it is not known whether the pig at this prepubertal
stage contains relaxin receptors after relaxin and estrogen
stimulation, the results reported here indicate that relaxin
regulates the growth and development of the uterus and
cervix during pregnancy as well as during the prepubertal
period.
Introduction
Relaxin is a pregnancy-associated polypeptide hormone.
Its primary target organs seem to be the components of
reproductive system such as the uterus and cervix. The main
physiological actions of relaxin are to prepare the birth canal
and to facilitate parturition. The specific effects of this
hormone include growth-promotion of the uterus and cervix,
suppression of uterine contractile activity and dilatation of
the uterine cervix. Most of these biological effects are
estrogen-dependent. In pigs, relaxin has been reported to
stimulate the growth of the uterus, cervix, and mammary
glands. Whether these effects of relaxin on uterine tissues are
estrogen-dependent or just augmented by estrogen is not
fully known. The present study was designed to determine
the effects of relaxin alone or in conjunction with estrogen
on the growth and modification of uterine connective tissue
of prepubertal gilts by measuring the concentration and
contents of DNA, protein and collagen in the tissues.
Materials and Methods
Animals and hormone treatments
Purebred Yorkshire gilts, 80 days old, were housed
indoors under controlled light and temperature conditions
during the experimental period. There were four treatment
groups: control (vehicle, 1 ml. PBS and 1 ml. vegetable
oil, n = 5); relaxin (relaxin, 1 ml., 167 mg. ml.-1, n = 5);
estradiol benzoate (EB, 1 ml., 2 mg. ml.-1, n = 5); and
relaxin plus EB (relaxin + EB, at the same doses, n = 5.
All treatments were administrated by intramuscular injection
every other day for two weeks (total six injections). To
eliminate variation from different litters, four littermates at
similar body weight from the same litter were randomly
assigned to the four treatment groups in each experiment.
Hysterectomy was performed 24 hours after the last hormone
or placebo injection and fresh weights (wet weight) of the
uterine horns and uterine cervix were determined. A 2-cm.
wide ring of the middle portion of the uterine (the location
with equal distance from each end of the uterine horn) and a
2-cm. wide ring from the middle portion of the cervix (the
location with equal distance from the internal and external
cervical os) were excised and weighed; one was immediately
frozen at -80°C until assayed for DNA, protein and
hydroxyproline contents, and the other was dried to a
constant weight in an oven at 100°C to determine the dry
weight and water content.
DNA determination
DNA concentrations and contents in tissue
homogenates were determined in duplicate, and calf thymus
DNA was used as an assay standard. A DNA fluorescent dye
(H33258, final concentrations of 1.0 mg. ml.-1) was used to
determine relative fluorescence; sensitivity of the assay was
5 ng. DNA ml.-1.
Protein assay
The protein contents in tissue homogenates were
determined in duplicate spectrophotometrically by using an
acidic solution of coomassie brilliant blue G-250.
Hydroxyproline determination
The homogenates of the uterine horn and cervix were
analyzed in duplicate for hydroxyproline concentration and
content. Acid hydrolysates of tissue homogenates were dried
down, and 1.0 ml. H2O was added to each tube and standard
tubes (1.0 ml., concentrations: 0, .5, 1.0, 1.5, 2.0, 3.0, 5.0,
7.5 and 15.0 hydroxyl-L-Proline mg. ml.-1), that included
.01 M CuSO4, 2.5 M NaOH, and 30% H2O2. After five
minutes, 100 ml. FeSO4 (.05 M) and 3 ml. rho-
dimethylamino benzaldehyde were added to each tube, and
absorbance was measured at 550 nM. The standard curve
was linear to 15 mg. and sensitive to .5 mg. ml.-1.
Statistical analysis
All samples related to DNA, hydroxyproline and
protein concentrations were measured in the same time in
each type of assay; there was no interassay variance to
report. The interaction of treatment by litter was used as the
error term to test significance.
Results and Discussion
The data for wet weight and dry weight of the uterus
and cervix are presented in Table 1. Relaxin alone did not
increase either the wet weight or dry weight of the uterus.
Estrogen or relaxin plus estrogen significantly increased
(P<.05 and P<.01, respectively) wet weight and dry weight
of the uterus compared with control. Compared with
estrogen alone, the relaxin plus estrogen significantly
(P<.05) stimulated the growth of the uterus; this effect can
be viewed as a relaxin effect being estrogen-dependent or a
synergistic interaction between relaxin and estrogen. Relaxin
alone did not significantly increase the wet weight or dry
weight of the cervix. Estrogen or relaxin plus estrogen
increased (P<.05 and P<.01, respectively) wet weight and
dry weight of the cervix compared with those of the
controls. Relaxin alone had no effect on DNA, protein,
hydroxyproline contents. Estrogen or relaxin plus estrogen
stimulated significantly (P<.05 and P<.01, respectively)
protein, hydroxyproline and DNA contents compared with
those of controls. The synergistic interaction between
relaxin and estrogen was significant (P<.05) on cervical
protein.
The present results indicate that the growth and
development of the uterus and cervix of the prepubertal pigs
can be accelerated by treatment with relaxin combined with
estrogen. After two weeks of sequential injections with
relaxin and estrogen, the uteri of the prepubertal pigs were
five-fold heavier than those of vehicle-injected animals. The
increased weight is reflected in the increase in DNA, protein,
collagen content and dry weight, but not the water content.
This indicates that normal growth and development can be
stimulated without affecting somatic growth because the
body weights at the end of treatment between the treatment
and control animals were not different (data not shown).
Similar phenomena were seen during precocious puberty
when growth of sexual organs was greater than that of other
somatic organs. Whether the mechanisms underlying these
two events (i.e., accelerated growth of the sexual organs in
pathological cases or experimentally induced as in this
study) were similar or not is unclear. In our present study,
the ratio of protein to DNA (an index of tissue hypertrophy
or cell size) was similar between treatment and control
groups. The ratios of hydroxyproline to DNA or protein
were not significantly different among the four treatment
groups (data not shown). Thus, we conclude that the
treatments with estrogen and relaxin induce the proportional
growth in uterine tissue.
Short-term treatments with high dosages of relaxin can
stimulate water imbibition. It seems that increase in uterine
wet weight and circumference may be due to the water
imbibition caused by this high dose of relaxin treatment
over a short period of the experiment. In contrast, the
present study showed that uterine weights, dry weights of
the uterus and cervix were significantly increased along with
the contents of DNA, protein and hydroxyproline of the
uterus (data not shown) and cervix.
The mechanism of the synergistic interaction between
relaxin and estrogen is not fully understood, but at least a
part of this interaction may result from estrogen's ability to
induce an increase in the number of relaxin receptors in the
uterine cervical cells as demonstrated in our previous study
(Huang et al., 1993).
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Table 1. Effect of relaxin and estrogen on growth of uterine cervix of prepubertal pigs.
     
No. DNA Protein Hydroxyproline
of       Uterus, g.      Cervix, g.   content, content, content,
pigs Wet Dry Wet Dry mg./cervix mg./cervix mg./cervix
PBS control 5 28 4.4 3.3 .58 2.1 190 13
Relaxin 5 36 5.6 4.1 .72 2.4 244 18
EB 5 85* 14.5* 9.9* 2.2* 5.4* 723* 46*
EB + relaxin 5 136** 22.6** 15.1** 3.3** 8.1** 979** 91**
*P<.05 compared with PBS control.
**P<.01 compared with PBS control.
